Literature DB >> 7855037

Insulin therapy and the reluctant patient. Overcoming obstacles to success.

E C Bashoff1, R S Beaser.   

Abstract

When diabetic patients learn that insulin therapy is necessary, they may feel overwhelmed by anticipated changes in lifestyle. The key to success is to realize that every person with diabetes has individual needs and that these must be assessed, addressed, and accommodated. Better diabetes control will be the result.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7855037

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  5 in total

1.  Delay in starting insulin after failure of other treatments in patients with type 2 diabetes mellitus.

Authors:  I Zografou; Mwj Strachan; J McKnight
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

2.  Needle with a novel attachment versus conventional screw-thread needles: a preference and usability test among adults with diabetes and impaired manual dexterity.

Authors:  Birtha Hansen; Søren K Lilleøre; Gitte Ter-Borch
Journal:  Diabetes Technol Ther       Date:  2011-03-15       Impact factor: 6.118

Review 3.  Overcoming barriers to glycemic control in African Americans with type-2 diabetes: benefits of insulin therapy.

Authors:  Merville C Marshall
Journal:  J Natl Med Assoc       Date:  2007-08       Impact factor: 1.798

Review 4.  Misadventures in insulin therapy: are you at risk?

Authors:  Matthew Grissinger; Michael Lease
Journal:  J Natl Med Assoc       Date:  2003-02       Impact factor: 1.798

5.  Depressive symptoms among elderly diabetic patients in Vietnam.

Authors:  Huyen Thi Thanh Vu; Thanh Xuan Nguyen; Huong Thi Thu Nguyen; Tu Anh Le; Tam Ngoc Nguyen; Anh Trung Nguyen; Thu Thi Hoai Nguyen; Hoang Long Nguyen; Cuong Tat Nguyen; Bach Xuan Tran; Carl A Latkin; Thang Pham; Melvyn Wb Zhang; Roger Cm Ho
Journal:  Diabetes Metab Syndr Obes       Date:  2018-10-23       Impact factor: 3.168

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.